{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-018393","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2025-07-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.895848+00:00","generated_at":"2026-05-18T08:52:00.327655+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Dare Bioscience shareholders approve 600,000-share increase to 2022 stock plan; re-elect directors","bullets":["Stockholders re-elected directors Matz, Rastetter, and Steele; each received >2.4M votes for.","Ratified Haskell & White LLP as independent auditor for FY2025 with 4.5M votes for, 106K against.","Advisory say-on-pay resolution approved with 2.38M votes for, 243K against.","Approved amendment increasing shares reserved under 2022 Stock Incentive Plan by 600,000 to 1,383,333."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-018393","json":"https://secwatch.observer/filing/0001641172-25-018393.json","markdown":"https://secwatch.observer/filing/0001641172-25-018393.md","text":"https://secwatch.observer/filing/0001641172-25-018393.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000164117225018393/0001641172-25-018393-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000164117225018393/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T08:52:00.327655+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}